JESSICA KRUMMEL: Open Payments
NPI 1629338637 · ELKTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 31 payments from 10 companies in 2025. Trend: 2023 $112 · 2024 $18 · 2025 $673
Food & beverage: $573Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 15 | $263 |
| Astellas Pharma US Inc | 7 | $216 |
| Evofem Biosciences, Inc. | 2 | $32 |
| Exeltis, USA Inc. | 1 | $30 |
| PFIZER INC. | 1 | $29 |
| Dynavax Technologies Corporation | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| CooperSurgical, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: ZURZUVAE, Veozah, Phexxi, SLYND, ABRYSVO, Heplisav-B, Mirena, Qelbree.
Industry payments across MD — which companies pay providers there.
